Zack Gray on Ophelia: Telemedicine's Role in Opioid Treatment
I founded the company with the entire mission being: let's make evidence-based treatment more accessible for the of Americans with opioid use disorder who are not getting treatment, many of whom have jobs and families and privacy concerns and simply can't go to a program.
What happens when you lose a loved one to an overdose? For Zack Gray, it sparked the creation of Ophelia, a telemedicine company dedicated to treating opioid dependence. In this episode of 'Rehab Confidential', hosts Joe Schrank and Amy Dresner chat with Zack about the urgent need for accessible, evidence-based treatment for opioid addiction. They dive into the stigma surrounding medication-assisted treatment (MAT) and why so many doctors face legal barriers to prescribing essential medications like Suboxone and Subutex.
Zack sheds light on the differences between these medications and the hurdles that exist in rural areas where medical oversight is often lacking. The conversation also touches on the business side of treatment and how telemedicine is revolutionizing the approach to rehab. Zack emphasizes that opioid dependence should be treated as a medical condition, not a moral failing, and discusses the cost implications of receiving versus not receiving treatment.
For anyone grappling with addiction or supporting someone who is, this episode offers a fresh perspective on the future of rehab and the critical role telemedicine can play. It's a candid, insightful discussion that challenges existing stigmas and looks towards innovative solutions in the fight against opioid dependence.